Search

Oxeladin

Withdrawn from the Canadian, US, and UK markets in 1976 due to carcinogenicity.

Vibrio cholerae CVD 103-HgR strain live antigen

[L12801] Cholera is an acute bacterial disease of the small intestine caused by _Vibrio cholerae_, which is gram-negative bacteria. … _Vibrio cholerae_ CVD 103-HgR strain live antigen is a component of Vaxchora, an oral vaccine for immunization against _Vibrio cholerae_ serogroup O1.

Equilin

An estrogenic steroid produced by horses. It has a total of four double bonds in the A- and B-ring. High concentration of equilin is found in the urine of pregnant mares.

Willow bark

Nirsevimab

[A254691] This is due to a modification in the Fc region of nirsevimab that grants it a longer half-time compared to typical monoclonal antibodies. … In addition, nirsevimab was developed as a single-dose treatment for all infants experiencing their first RSV season, whereas palivizumab requires five monthly doses to cover an RSV season.

Cobimetinib

Cobimetinib is an orally active, potent and highly selective small molecule inhibiting mitogen-activated protein kinase kinase 1 (MAP2K1 or MEK1), and central components of the RAS/RAF/MEK/ERK signal transduction

Scorpion (centruroides) immune Fab2 antivenin (equine)

Envenomation by a scorpion sting can result in serious cardiovascular effects [A32483]. … Most commonly, children experience severe reactions, however, adults can be affected, too [L2195], [L2196], [L2198].

Garadacimab

[L53283,A273998] Garadacimab received its first approval in Australia and the UK in January 2025, and has since been approved in a number of other jurisdictions, including the EU and Japan.

Fominoben

Fominoben is an antitussive agent.

Lime (citrus)

Lime (citrus) allergenic extract is used in allergenic testing.